Protocol GS-US-259-1837, ???A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Ranolazine in Male Subjects with Duchenne Muscular Dystrophy (DMD) and Declining Upper Extremity Function
|Effective start/end date||10/2/15 → 11/13/15|
- Gilead Sciences, Inc.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.